Buscar

Mostrando ítems 1-10 de 25

Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil

Silva, Thiago Cerqueira; Andrews, Jason R.; Boaventura, Viviane S.; Ranzani, Otavio T.; Oliveira, Vinicius de Araújo; Paixão, Enny S.; Bertoldo Júnior, Juracy; Machado, Tales Mota; Hitchings, Matt D.T.; Dorion, Murilo; Lind, Margaret L.; Penna, Gerson Oliveira; Cummings, Derek A.T.; Dean, Natalie E.; Werneck, Guilherme Loureiro; Barreto, Maurício Lima; Ko, Albert Icksang; Croda, Julio; Barral Netto, Manoel (Yale University, 2022)

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Silva, Thiago Cerqueira; Andrews, Jason R.; Boaventura, Viviane S.; Ranzani, Otavio T.; Oliveira, Vinicius de Araújo; Paixão, Enny S.; Bertoldo Júnior, Juracy; Machado, Tales Mota; Hitchings, Matt D. T.; Dorion, Murilo; Lind, Margaret L.; Penna, Gerson O.; Cummings, Derek A. T.; Dean, Natalie E.; Werneck, Guilherme Loureiro; Pearce, Neil; Barreto, Mauricio L.; Ko, Albert I.; Croda, Julio; Barral-Netto, Manoel (Elsevier, 2022)

Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Silva, Thiago Cerqueira; Andrews, Jason R.; Boaventura, Viviane S.; Ranzani, Otavio T.; Oliveira, Vinicius de Araújo; Paixão, Enny S.; Bertoldo Júnior, Juracy; Machado, Tales Mota; Hitchings, Matt D. T.; Dorion, Murilo; Lind, Margaret L.; Penna, Gerson O.; Cummings, Derek A. T.; Dean, Natalie E.; Werneck, Guilherme Loureiro; Pearce, Neil; Barreto, Mauricio L.; Ko, Albert I.; Croda, Julio; Barral-Netto, Manoel (Elsevier, 2022)

Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

Autor desconocido (Springer, 2022)

The objective of this study is to identify post SARS-CoV-2 vaccine BNT162b2 (BioNTech & Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano Heredia Hospital, Lima, Peru. A descriptive ...

Revisión sistemática de las principales vacunas contra el SARS-COV-2: Desarrollo, ensayos clínicos y preclínicos, Arequipa, 2021

Ponce Abarca, Elvis Emiliano (Universidad Nacional de San Agustín de ArequipaPE, 2021)

La pandemia actual de COVID-19, causada por el SARS-CoV-2, es un desafío sin precedentes para la humanidad. Se detectó por primera vez en diciembre de 2019 en Wuhan China. COVID-19 ha infectado a más de 112 millones de ...

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Clemens, Sue Ann Costa; Weckx, Lily; Clemens, Ralf; Mendes, Ana Verena Almeida; Souza, Alessandra Ramos; Silveira, Mariana B V; Guarda, Suzete Nascimento Farias da; Nobrega, Maristela Miyamoto de; Pinto, Maria Isabel de Moraes; Gonzalez, Isabela G S; Salvador, Natalia; Franco, Marilia Miranda; Mendonça, Renata Navis de Avila; Oliveira, Isabelle Silva Queiroz; Souza, Bruno Solano de Freitas; Fraga, Mayara; Aley, Parvinder; Bibi, Sagida; Cantrell, Liberty; Dejnirattisai, Wanwisa; Liu, Xinxue; Mongkolsapaya, Juthathip; Supasa, Piyada; Screaton, Gavin R; Lambe, Teresa; Voysey, Merryn; Pollard, Andrew J (Elsevier, 2022)

The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case–control study

Kahn, Rebecca; Janusz, Cara B.; Castro, Marcia C.; Matos, Aline da Rocha; Domingues, Carla; Ponmattam, Jamie; Rey-Benito, Gloria; Toscano, Cristiana M.; Oliveira, Lucia Helena de; Regional COVID-19 VE in Adults Study Working Group (Elsevier Ltd., 2023)

Dosis aplicadas contra COVID-19 por laboratorio en las entidades territoriales de Colombia

Díaz Pinzón, Jorge Enrique (Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2021-03-08)

Randomized immunogenicity and safety study of heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine

Clemens, Sue Ann Costa; Weck, Lily; Clemen, Ralf; Mendes, Ana Verena Almeida; Souza, Alessandra Ramos; Silveira, Mariana B. V.; Guarda, Suzete Nascimento Farias da; Nobrega, Maristela Miyamoto de; Pinto, Maria Isabel de Moraes; Gonzalez, Isabela G. S.; Salvador, Natalia; Franco, Marilia Miranda; Mendonça, Renata Navis de Avila; Oliveira, Isabelle Silva Queiroz; Souza, Bruno Solano de Freitas; Fraga, Mayara; Aley, Parvinder; Bibi, Sagida; Cantrell, Liberty; Lambe, Teresa; Voysey, Merryn; Pollard, Andrew J. (Elsevier, 2022)

Buscar

Filtros

Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

Revisión sistemática de las principales vacunas contra el SARS-COV-2: Desarrollo, ensayos clínicos y preclínicos, Arequipa, 2021

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case–control study

Dosis aplicadas contra COVID-19 por laboratorio en las entidades territoriales de Colombia

Randomized immunogenicity and safety study of heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine